Pharma-Bio Serv Shares Outstanding 2012-2026 | PBSV
Pharma-Bio Serv shares outstanding from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Pharma-Bio Serv Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 23 |
| 2024 | 23 |
| 2023 | 23 |
| 2022 | 23 |
| 2021 | 23 |
| 2020 | 23 |
| 2019 | 23 |
| 2018 | 23 |
| 2017 | 23 |
| 2016 | 23 |
| 2015 | 23 |
| 2014 | 24 |
| 2013 | 24 |
| 2012 | 23 |
| 2011 | 23 |
|
Pharma-Bio Serv Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-07-31 | 23 |
| 2026-04-30 | 23 |
| 2026-01-31 | 23 |
| 2025-10-31 | 23 |
| 2025-07-31 | 23 |
| 2025-04-30 | 23 |
| 2025-01-31 | 23 |
| 2024-10-31 | 23 |
| 2024-07-31 | 23 |
| 2024-04-30 | 23 |
| 2024-01-31 | 23 |
| 2023-10-31 | 23 |
| 2023-07-31 | 23 |
| 2023-04-30 | 23 |
| 2023-01-31 | 23 |
| 2022-10-31 | 23 |
| 2022-07-31 | 23 |
| 2022-04-30 | 23 |
| 2022-01-31 | 23 |
| 2021-10-31 | 23 |
| 2021-07-31 | 23 |
| 2021-04-30 | 23 |
| 2021-01-31 | 23 |
| 2020-10-31 | 23 |
| 2020-07-31 | 23 |
| 2020-04-30 | 23 |
| 2020-01-31 | 23 |
| 2019-10-31 | 23 |
| 2019-07-31 | 23 |
| 2019-04-30 | 23 |
| 2019-01-31 | 23 |
| 2018-10-31 | 23 |
| 2018-07-31 | 23 |
| 2018-04-30 | 23 |
| 2018-01-31 | 23 |
| 2017-10-31 | 23 |
| 2017-07-31 | 23 |
| 2017-04-30 | 23 |
| 2017-01-31 | 23 |
| 2016-10-31 | 23 |
| 2016-07-31 | 23 |
| 2016-04-30 | 23 |
| 2016-01-31 | 23 |
| 2015-10-31 | 23 |
| 2015-07-31 | 23 |
| 2015-04-30 | 23 |
| 2015-01-31 | 23 |
| 2014-10-31 | 24 |
| 2014-07-31 | 24 |
| 2014-04-30 | 24 |
| 2014-01-31 | 24 |
| 2013-10-31 | 24 |
| 2013-07-31 | 23 |
| 2013-04-30 | 23 |
| 2013-01-31 | 23 |
| 2012-10-31 | 23 |
| 2012-07-31 | 23 |
| 2012-04-30 | 23 |
| 2012-01-31 | 23 |
| 2011-10-31 | 23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Consulting Services | $0.009B | $0.009B |
| Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Equifax (EFX) | United States | $19.244B | 19.88 |
| Bureau Veritas Registre De Classification (BVRDF) | France | $14.189B | 0.00 |
| Gartner (IT) | United States | $12.097B | 13.31 |
| Booz Allen Hamilton Holding (BAH) | United States | $9.432B | 11.45 |
| Stantec (STN) | Canada | $7.914B | 17.01 |
| FTI Consulting (FCN) | United States | $4.007B | 17.19 |
| Exponent (EXPO) | United States | $3.234B | 30.50 |
| CBIZ (CBZ) | United States | $2.963B | 14.68 |
| Huron Consulting Group (HURN) | United States | $2.451B | 18.21 |
| Charles River Associates (CRAI) | United States | $1.032B | 19.88 |
| Hackett (HCKT) | United States | $0.273B | 10.88 |
| Information Services (III) | United States | $0.255B | 20.27 |
| Franklin Covey (FC) | United States | $0.201B | 24.74 |
| Accos (ACCL) | Hong Kong, SAR China | $0.040B | 0.00 |
| ATIF Holdings (ZBAI) | China | $0.011B | 0.00 |
| ATIF Holdings (AUC) | China | $0.009B | 0.00 |